Testing effectiveness (Phase 2)Looking for participantsNCT06728852
What this trial is testing
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)Recurrent or Metastatic Lung CancerThird-line and Beyond Therapy+1 more
Li-kun Chen 32